Initial human experience with the Amplatzer perimembranous ventricular septal occluder device

John L. Bass, G. S. Kalra, Ramesh Arora, Jozef Masura, Pavlo Gavora, Basil D. Thanopoulos, William Torres, Horst Sievert, Mario Carminati, Gunther Fischer, Peter Ewert

Research output: Contribution to journalArticle

Abstract

Transcatheter closure of perimembranous ventricular septal defects with coils or devices designed to close other lesions may be complicated by embolization or aortic insufficiency. A new asymmetric Amplatzer perimembranous ventricular septal occluder and delivery system was specifically designed for perimembranous defects. This report describes the first use of this device in 27 patients. Implantation was successful in 25 (93%), with 1 removed for device-related aortic insufficiency and inability to position the delivery sheath in another. Device orientation was excellent when the device was initially advanced through a standard delivery sheath positioned in the left ventricular apex. Twenty-three had complete occlusion within 1 week (92%), with a tiny (<2 mm) residual shunt in the other two. In the 25 subjects with the device left in place, device-related aortic or tricuspid insufficiency, arrhythmias, and embolization were not observed. These excellent acute results need to be confirmed by long-term follow-up.

Original languageEnglish
Pages (from-to)238-245
Number of pages8
JournalCatheterization and Cardiovascular Interventions
Volume58
Issue number2
DOIs
Publication statusPublished - Feb 1 2003

Fingerprint

Septal Occluder Device
Equipment and Supplies
Ventricular Heart Septal Defects
Cardiac Arrhythmias

Keywords

  • Catheterization
  • Heart septal defects
  • Shunts

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Bass, J. L., Kalra, G. S., Arora, R., Masura, J., Gavora, P., Thanopoulos, B. D., ... Ewert, P. (2003). Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheterization and Cardiovascular Interventions, 58(2), 238-245. https://doi.org/10.1002/ccd.10406

Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. / Bass, John L.; Kalra, G. S.; Arora, Ramesh; Masura, Jozef; Gavora, Pavlo; Thanopoulos, Basil D.; Torres, William; Sievert, Horst; Carminati, Mario; Fischer, Gunther; Ewert, Peter.

In: Catheterization and Cardiovascular Interventions, Vol. 58, No. 2, 01.02.2003, p. 238-245.

Research output: Contribution to journalArticle

Bass, JL, Kalra, GS, Arora, R, Masura, J, Gavora, P, Thanopoulos, BD, Torres, W, Sievert, H, Carminati, M, Fischer, G & Ewert, P 2003, 'Initial human experience with the Amplatzer perimembranous ventricular septal occluder device', Catheterization and Cardiovascular Interventions, vol. 58, no. 2, pp. 238-245. https://doi.org/10.1002/ccd.10406
Bass, John L. ; Kalra, G. S. ; Arora, Ramesh ; Masura, Jozef ; Gavora, Pavlo ; Thanopoulos, Basil D. ; Torres, William ; Sievert, Horst ; Carminati, Mario ; Fischer, Gunther ; Ewert, Peter. / Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. In: Catheterization and Cardiovascular Interventions. 2003 ; Vol. 58, No. 2. pp. 238-245.
@article{4b6de9f285d14c569f68dac3b4ffc75c,
title = "Initial human experience with the Amplatzer perimembranous ventricular septal occluder device",
abstract = "Transcatheter closure of perimembranous ventricular septal defects with coils or devices designed to close other lesions may be complicated by embolization or aortic insufficiency. A new asymmetric Amplatzer perimembranous ventricular septal occluder and delivery system was specifically designed for perimembranous defects. This report describes the first use of this device in 27 patients. Implantation was successful in 25 (93{\%}), with 1 removed for device-related aortic insufficiency and inability to position the delivery sheath in another. Device orientation was excellent when the device was initially advanced through a standard delivery sheath positioned in the left ventricular apex. Twenty-three had complete occlusion within 1 week (92{\%}), with a tiny (<2 mm) residual shunt in the other two. In the 25 subjects with the device left in place, device-related aortic or tricuspid insufficiency, arrhythmias, and embolization were not observed. These excellent acute results need to be confirmed by long-term follow-up.",
keywords = "Catheterization, Heart septal defects, Shunts",
author = "Bass, {John L.} and Kalra, {G. S.} and Ramesh Arora and Jozef Masura and Pavlo Gavora and Thanopoulos, {Basil D.} and William Torres and Horst Sievert and Mario Carminati and Gunther Fischer and Peter Ewert",
year = "2003",
month = "2",
day = "1",
doi = "10.1002/ccd.10406",
language = "English",
volume = "58",
pages = "238--245",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Initial human experience with the Amplatzer perimembranous ventricular septal occluder device

AU - Bass, John L.

AU - Kalra, G. S.

AU - Arora, Ramesh

AU - Masura, Jozef

AU - Gavora, Pavlo

AU - Thanopoulos, Basil D.

AU - Torres, William

AU - Sievert, Horst

AU - Carminati, Mario

AU - Fischer, Gunther

AU - Ewert, Peter

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Transcatheter closure of perimembranous ventricular septal defects with coils or devices designed to close other lesions may be complicated by embolization or aortic insufficiency. A new asymmetric Amplatzer perimembranous ventricular septal occluder and delivery system was specifically designed for perimembranous defects. This report describes the first use of this device in 27 patients. Implantation was successful in 25 (93%), with 1 removed for device-related aortic insufficiency and inability to position the delivery sheath in another. Device orientation was excellent when the device was initially advanced through a standard delivery sheath positioned in the left ventricular apex. Twenty-three had complete occlusion within 1 week (92%), with a tiny (<2 mm) residual shunt in the other two. In the 25 subjects with the device left in place, device-related aortic or tricuspid insufficiency, arrhythmias, and embolization were not observed. These excellent acute results need to be confirmed by long-term follow-up.

AB - Transcatheter closure of perimembranous ventricular septal defects with coils or devices designed to close other lesions may be complicated by embolization or aortic insufficiency. A new asymmetric Amplatzer perimembranous ventricular septal occluder and delivery system was specifically designed for perimembranous defects. This report describes the first use of this device in 27 patients. Implantation was successful in 25 (93%), with 1 removed for device-related aortic insufficiency and inability to position the delivery sheath in another. Device orientation was excellent when the device was initially advanced through a standard delivery sheath positioned in the left ventricular apex. Twenty-three had complete occlusion within 1 week (92%), with a tiny (<2 mm) residual shunt in the other two. In the 25 subjects with the device left in place, device-related aortic or tricuspid insufficiency, arrhythmias, and embolization were not observed. These excellent acute results need to be confirmed by long-term follow-up.

KW - Catheterization

KW - Heart septal defects

KW - Shunts

UR - http://www.scopus.com/inward/record.url?scp=0037308459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037308459&partnerID=8YFLogxK

U2 - 10.1002/ccd.10406

DO - 10.1002/ccd.10406

M3 - Article

C2 - 12552550

AN - SCOPUS:0037308459

VL - 58

SP - 238

EP - 245

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 2

ER -